Goodwin Law

At Goodwin, we are a long-term partner to our clients and have deep experience supporting founders from company formation and initial fundraising through all financings, private and public, and liquidity events including secondaries, M&A, IPO & SPACs. With our focus on technology and life sciences, we are sector-focused and stage-agnostic.

• Better Dairy
  • $22 million – Series B
• Cleo
  • $80 million – Series C
• Closed Loop Medicine
  • £13 million -Financing
• Quanta Dialysis
  • £245 million – Series D
• Vaccitech
  • £168 million – Series B
• Mojo
  • $4.4 million – Seed
• Selina
  • $150 million – Series B
• Growth Kitchen
  • £3 million – Seed
• Zapp
  • Undisclosed – Series B
• Matillion
  • $150 million – Series E
• Vivid Money
  • $114 million – Series C
• Omnipresent
  • $11 million – Series A
• Hopin
  • $450 million – Series D
• Tranch
  • $4.25 million – Pre seed
• MiroBio
  • $97 million – Series B
• Evox Therapeutics
  • £69.2 million – Series C